References
- Adjei IM, Sharma B, Labhasetwar V. (2014). Nanoparticles: cellular uptake and cytotoxicity. Adv Exp Med Biol 811:73–91.
- Deng L, Cai X, Sheng D, et al. (2017). A laser-activated biocompatible theranostic nanoagent for targeted multimodal imaging and photothermal therapy. Theranostics 7:4410–23.
- Dixon SJ, Lemberg KM, Lamprecht MR, et al. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–72.
- Eaton JK, Furst L, Ruberto RA, et al. (2020). Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol 16:497–506.
- Glickman RD. (2021). Photoacoustic imaging and sensing: a new way to see the eye. J Ocul Pharmacol Ther 37:162–71.
- Goyette MA, Elkholi IE, Apcher C, et al. (2021). Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels. Proc Natl Acad Sci USA 118:e2023868118.
- Guo X, Yang N, Ji W, et al. (2021). Mito-Bomb: targeting mitochondria for cancer therapy. Adv Mater 33:e2007778.
- Han X, Song Z, Zhou Y, et al. (2021). Mitochondria-targeted high-load sound-sensitive micelles for sonodynamic therapy to treat triple-negative breast cancer and inhibit metastasis. Mater Sci Eng C Mater Biol Appl 124:112054.
- Hirschhorn T, Stockwell BR. (2019). The development of the concept of ferroptosis. Free Radic Biol Med 133:130–43.
- Jiang F, Yang C, Ding B, et al. (2022). Tumor microenvironment-responsive MnSiO3-Pt@BSA-Ce6 nanoplatform for synergistic catalysis-enhanced sonodynamic and chemodynamic cancer therapy. Chin Chem Lett 33:2959–64.
- Kim Y, Nam HJ, Lee J, et al. (2016). Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis. Nat Commun 7:10347.
- Lafond M, Yoshizawa S, Umemura SI. (2019). Sonodynamic therapy: advances and challenges in clinical translation. J Ultrasound Med 38:567–80.
- Li J, Cao F, Yin HL, et al. (2020). Ferroptosis: past, present and future. Cell Death Dis 11:88.
- Li X, Luo R, Liang X, et al. (2022). Recent advances in enhancing reactive oxygen species based chemodynamic therapy. Chin Chem Lett 33:2213–30.
- Liew SS, Qin X, Zhou J, et al. (2021). Smart design of nanomaterials for mitochondria-targeted nanotherapeutics. Angew Chem Int Ed Engl 60:2232–56.
- Luo L, Wang H, Tian W, et al. (2021). Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics 11:9937–52.
- Pathania D, Millard M, Neamati N. (2009). Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv Drug Deliv Rev 61:1250–75.
- Qu F, Wang P, Zhang K, et al. (2020). Manipulation of mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy. Autophagy 16:1413–35.
- Shintoku R, Takigawa Y, Yamada K, et al. (2017). Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3. Cancer Sci 108:2187–94.
- Son S, Kim JH, Wang X, et al. (2020). Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev 49:3244–61.
- Steinberg I, Huland DM, Vermesh O, et al. (2019). Photoacoustic clinical imaging. Photoacoustics 14:77–98.
- Stockwell BR, Friedmann Angeli JP, Bayir H, et al. (2017). Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273–85.
- Su LJ, Zhang JH, Gomez H, et al. (2019). Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev 2019:5080843.
- Sun LL, Linghu DL, Hung MC. (2021). Ferroptosis: a promising target for cancer immunotherapy. Am J Cancer Res 11:5856–63.
- Tang D, Chen X, Kang R, et al. (2021). Ferroptosis: molecular mechanisms and health implications. Cell Res 31:107–25.
- Ursini F, Maiorino M. (2020). Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med 152:175–85.
- Wang L, Niu M, Zheng C, et al. (2018). A core–shell nanoplatform for synergistic enhanced sonodynamic therapy of hypoxic tumor via cascaded strategy. Adv Healthc Mater 7:e1800819.
- Wang YW, Fu YY, Peng Q, et al. (2013). Dye-enhanced graphene oxide for photothermal therapy and photoacoustic imaging. J Mater Chem B 1:5762–7.
- Wei Y, Lv H, Shaikh AB, et al. (2020). Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy. Biochim Biophys Acta Gen Subj 1864:129539.
- Xu C, Sun S, Johnson T, et al. (2021). The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep 35:109235.
- Yang WS, SriRamaratnam R, Welsch ME, et al. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317–31.
- Yao X, Xie R, Cao Y, et al. (2021). Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnol 19:311.
- Zhang C, Liu T, Su Y, et al. (2010). A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials 31:6612–7.
- Zhang L, Wang D, Yang K, et al. (2018). Mitochondria-targeted artificial "Nano-RBCs" for amplified synergistic cancer phototherapy by a single NIR irradiation. Adv Sci (Weinh) 5:1800049.
- Zhang P, Zhang L, Wang J, et al. (2021a). An intelligent hypoxia-relieving chitosan-based nanoplatform for enhanced targeted chemo-sonodynamic combination therapy on lung cancer. Carbohydr Polym 274:118655.
- Zhang Y, Zhang X, Yang H, et al. (2021b). Advanced biotechnology-assisted precise sonodynamic therapy. Chem Soc Rev 50:11227–48.
- Zong WX, Rabinowitz JD, White E. (2016). Mitochondria and Cancer. Mol Cell 61:667–76.